SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

Zydus Lifesciences

BSE: 532321 01 Jun 2025
Healthcare
₹ 926.15
Zydus Lifesciences Limited specializes in Pharmaceuticals within the Healthcare sector.

Zydus Lifesciences - Share Price & Details

Market Cap
₹93,580
High /Low
1,324 / 795.0
Stock P/E
20.1
Book Value
₹238.0
Dividend Yield
0.32
ROCE
24.4
ROE
₹21.3
Face Value
1.0
PEG Ratio
0.77
EVEBITDA
₹12.8
Debt
3,213
CMP / FCF
30.6
Debt to equity
₹0.13
NP Ann
4,673
High price all time
1,324
Piotroski score
₹6.0
Graham Number
491.0
No. Eq. Shares
101.0
Net CF
₹419
Net profit
4,673
Price to book value
3.91
Interest Coverage
₹38.6
Low price all time
25.5
Industry PE
33.5
Reserves
₹23,852
Free Cash Flow
₹5,116

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Shyama Computronics and ServicNANANANA4.6330.9
Triochem Products Ltd.,NANANANA0
Zydus Lifesciences Limited60050.028137.058196.027.9693,58020.1
LUPIN LTD.45344.612913.544856.728.218939227.2
AUROBINDO PHARMA LTD.NANANANA6725419.3

Peer Comparison Chart


About Zydus Lifesciences

Zydus Lifesciences Limited, with Security Code 532321, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Zydus Lifesciences To Subscribe To Equity Shares Of Torrent Urja 26

(28 May 2025)
Zydus Lifesciences Limited is an India-based global life sciences company that discovers, develops, manufactures and markets a broad range...
Read more →

Zydus Lifesciences' Usnoflast receives USFDA fast track designation for ALS Treatment

(28 May 2025)
Zydus Lifesciences announced that the U.S. Food and Drug Administration (USFDA) has granted Fast Track Designation to Usnoflast (ZYIL1),...
Read more →

Zydus Life says USFDA grants fast track designation for neurodegenerative disease treatment drug

(28 May 2025)
Shares of Zydus Lifesciences Ltd. gained on Wednesday, May 28, after the company said the US Food and Drug Administration (USFDA) has...
Read more →

Stock Picks: Sagar Doshi suggests Chennai Petroleum, LTIMindtree, Zydus Life shares to buy in a muted market today

(28 May 2025)
Stock Picks: Sagar Doshi of Nuvama Professional Clients Group recommends these three stocks today - Chennai Petroleum Corporation Ltd,...
Read more →

USFDA grants Fast Track Designation to Zydus Usnoflast for amyotrophic lateral sclerosis

(28 May 2025)
Ahmedabad: Zydus, a discovery-based, global pharmaceutical company, has announced that the USFDA has granted 'Fast Track Designation' to...
Read more →

Zydus To Continue Mirabegron Sales

(26 May 2025)
Zydus expects strong mirabegron sales in FY26 amid US litigation even as it builds a growth pillar in vaccines with a world-first,...
Read more →